NCT01166633View on ClinicalTrials.gov

Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

February 28, 2011

Conditions

Hypercholesterolemia

Interventions

DRUG

pitavastatin

pitavastatin 2mg per daily

DRUG

atorvastatin

atorvastatin 10mg per daily

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY